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There is some evidence for a nutritional interaction between vitamin D and vitamin K status. We have recently reported that serum percentage
undercarboxylated osteocalcin (%ucOC; a marker of vitamin K status) was inversely correlated with serum 25-hydroxyvitamin D (25(OH)D)
concentration (reflective of vitamin D status) in healthy Danish girls (aged 11–12 years), in line with a similar relationship reported in elderly
women. While the causal nature of the relationship between vitamin D status and serum %ucOC has been tested in studies of elderly women,
it has not been investigated in children. The objective of the present study was to test the hypothesis that improving vitamin D status significantly
lowers serum %ucOC. Serum samples from sixty-seven healthy Danish girls (aged 11–12 years), who participated in a 12-month double-blind,
placebo-controlled, vitamin D3 intervention trial were used for the present study. These girls were a subset of subjects which began and finished the
intervention during wintertime, thus avoiding the influence of seasonality on vitamin D status. A total of thirty-three and thirty-four of the girls had
been randomised to treatment with 10mg vitamin D3 per d and placebo, respectively, for 12 months. Total osteocalcin and the fraction of ucOC in
serum (via enzyme-immunoassay) as well as serum 25(OH)D (via HPLC) were assessed at baseline and end-point. Vitamin D3 supplementation
significantly increased serum 25(OH)D (21·6 %; P,0·002) but had no effect on serum %ucOC (P.0·8). In conclusion, the findings of the present
intervention study in young girls suggest that vitamin D supplementation does not affect serum %ucOC, a marker of vitamin K status.
Vitamin D: Vitamin K: Undercarboxylated osteocalcin: Girls: Interactions
Vitamin K is a cofactor for the vitamin K-dependent carboxylase,
a microsomal enzyme that facilitates the post-translational
conversion of glutamyl to g-carboxyglutamyl (Gla) residues(1).
Its classic role in this respect involves the synthesis of several
coagulation factors(2–4). More recently, the identification of
Gla-containing proteins in bone, notably osteocalcin and
matrix Gla protein, has generated much interest in the role of
vitamin K in bone metabolism and bone health(4–7). The
circulating concentration of under-g-carboxylated osteocalcin
(ucOC), a sensitive marker of vitamin K nutritional status(8,9),
has been reported to be a marker of hip fracture risk and a
predictor of bone mineral density in adults(6,10–17). More recently,
higher serum ucOC has been associated with increased bone
turnover(18) and lower bone mineral content(19) in young girls.
The synthesis of functional osteocalcin depends on both
vitamin D and vitamin K(10). Vitamin D (as 1,25-dihydroxy-
vitamin D3) induces the synthesis of osteocalcin by
promoting the transcription of its gene(20), while vitamin K
is needed for its g-carboxylation, as mentioned already.
There is some in vitro evidence, however, that vitamin D
might stimulate the g-carboxylation of osteocalcin and other
Gla-containing proteins(21,22). Szulc et al.(10) have suggested
that these observations could be relevant to the age-related
impairment of the g-carboxylation of osteocalcin, in that vita-
min D deficiency is a common feature of elderly populations.
However, vitamin D deficiency is also very common during
adolescence, a period of rapid bone development (for a
review, see Cashman(23)).
We have recently reported that serum %ucOC was inversely
correlated with serum 25-hydroxyvitamin D (25(OH)D)
levels, the most widely used marker of vitamin D status, in
healthy Danish girls (aged 11–12 years)(19). This is in line
with a similar relationship reported in elderly women(10).
In both studies, serum %ucOC as well as serum 25(OH)D
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concentrations exhibited clear seasonal variation (with lowest
and highest values, respectively, evident in late summer/early
autumn)(10,19). Furthermore, serum %ucOC was correlated
with sun exposure in the study by Szulc et al.(10). In a longi-
tudinal 1-year follow-up study, Szulc et al.(10) showed that
vitamin D plus Ca supplementation significantly reduced the
%ucOC in elderly women. However, Bolton-Smith et al.(24)
in a 2-year vitamin K and/or vitamin D plus Ca randomised
control intervention trial in elderly women showed that
vitamin D plus Ca had no effect on %ucOC. Whether the
relationship between vitamin D status and serum %ucOC is
causal in children has not been investigated.
Therefore, the objective of the present study was to test the
hypothesis that improving vitamin D status in young adoles-
cent girls would significantly lower serum %ucOC. This was
possible by using data and samples available from a random-
ised, double-blind, placebo-controlled, 12-month vitamin D3
intervention study in Danish girls, aged 11–12 years(25).
Subjects and methods
Subjects
Our initial study investigated the relationship between vitamin
K status and bone health indices in 223 Danish girls, aged
between 10·9 and 11·9 years(19). These girls were recruited
for participation in a 12-month vitamin D3 intervention trial
on bone health (as part of the Optimal Strategy for Vitamin
D Fortification (OPTIFORD) project; http://www.optiford.
org), details of which have been described previously(19,25).
Of the 221 girls who completed the double-blind, placebo-
controlled vitamin D intervention trial, sixty-seven subjects
were selected as a subset who began and finished the interven-
tion during wintertime (November to April), and who were
randomised to receive either placebo (n 34) or 10mg vitamin
D3 (n 33) for 12 months. Selection of this wintertime subgroup
avoided the influence of seasonality on vitamin D status. The
present study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all procedures
involving human subjects were approved by the Research
Ethical Committee of Copenhagen and Frederiksberg (J.nr
(KF) 01-129/01). Written informed consent was obtained
from the parent or guardian of each participant.
Design
This was a double-blind, placebo-controlled vitamin D3
intervention trial, which in the context of the present work
examined the effect of improving vitamin D status on serum
%ucOC, as a widely used marker of vitamin K status(26), in
a cohort of healthy young Danish girls, aged 10·9–11·9
years. After an overnight fast, a blood sample (10 ml) was
taken between 08.00 and 10.00 hours from each subject. On
the same day as blood sampling, each girl, with the help of
their parent or guardian and a trained researcher, completed
various questionnaires, including a general health and lifestyle
questionnaire, a FFQ, a physical activity questionnaire, and a
pubertal status questionnaire, as described previously(19,25).
Anthropometric measurements (weight and height) were also
taken at this time. Pubertal status was assessed and physical
activity recorded in each subject, as described previously(19).
Collection and preparation of samples
Fasting blood was collected by venepuncture into vacutainer
tubes with no additive and was processed to serum, which
was immediately stored at 2808C until required for analysis.
Experimental techniques
Details of the analytical methodology for serum total osteocal-
cin and ucOC as well as 25(OH)D have been described in
detail elsewhere(19,27). In brief, total (intact) osteocalcin
levels were measured in serum samples using an ELISA
(Metrae Osteocalcin EIA Kit; Quidel Corporation, San
Diego, CA, USA). The intra- and inter-assay CV was 6·0
and 7·6 %, respectively. ucOC was measured by treating
60ml of serum samples with 30ml of hydroxyapatite (15 mg/
ml) (Calbiochem, Merck Biosciences, Bestor, Nottingham,
UK). Samples were shaken for 1 h at room temperature and
then centrifuged for 5 min. ucOC in the supernatant fractions
was quantified using the Metrae Osteocalcin EIA Kit. ucOC
was expressed as the percentage of total osteocalcin
(%ucOC). The intra- and inter-assay CV was 9·5 and
12·8 %, respectively. Serum 25(OH)D levels were measured
by an HPLC-based method.
Statistical methods
We have previously shown that %ucOC was significantly
lower (14 %) during summer compared with wintertime in
these girls, coinciding with better vitamin D status in
summer also(19). Therefore, using the mean and standard devi-
ation of serum %ucOC in the girls in the present study at base-
line and the percentage difference between summer and
winter, possibly arising from improved vitamin D status (our
hypothesis), we calculated we needed thirty subjects per
group. Serum 25(OH)D and %ucOC were normally distributed
as determined by Kolmorgorov–Smirnov tests and allowed for
parametric statistical analysis. Data are presented as means
and standard deviations. Baseline characteristics were com-
pared between the placebo and vitamin D-supplemented
group by unpaired Student’s t tests and x2 where appropriate.
The effect of vitamin D3 supplementation on serum 25(OH)D
concentration, %ucOC and total osteocalcin in the placebo and
10mg vitamin D-supplemented groups was evaluated by
repeated-measures ANOVA. Paired Student’s t tests were
used to compare serum 25(OH)D concentrations at baseline
v. end-point in both the placebo and vitamin D-supplemented
groups. P,0·05 was considered significant.
Results
The mean age, height, weight, BMI, serum 25(OH)D and
serum %ucOC of the girls were 11·3 (SD 0·2) years, 148·6
(SD 6·4) cm, 40·1 (SD 7·3) kg, 18·1 (SD 2·8) kg/m2, 36·0
(SD 12·1) nmol/l and 23·2 (SD 4·4) %, respectively. There
were no significant differences in these baseline characteristics
between the placebo and vitamin D-supplemented group (data
not shown).
The effect of vitamin D3 supplementation on biochemical
indices of vitamin D and vitamin K status in the Danish
girls is shown in Table 1. There was no significant difference
E. O’Connor et al.1092
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in serum 25(OH)D concentration or %ucOC between the
placebo and vitamin D-supplemented groups at baseline.
Repeated-measures ANOVA showed a significant time
£ treatment group interaction (P,0·0001) in serum 25(OH)D
concentration. While serum 25(OH)D concentration decreased
(216·9 %; P,0·003) from baseline to end-point in the
placebo group, it significantly increased (21·6 %; P,0·002)
in the supplemented group. There was no significant
time £ treatment group interaction (P.0·79) in serum %ucOC.
There was, however, a significant change over time (from
baseline to end-point) in serum %ucOC, with similar
increases in the placebo and vitamin D-supplemented groups
(15·8 and 18·6 %, respectively). There was no significant
time £ treatment group interaction (P.0·65) in serum total
osteocalcin (data not shown).
Discussion
Interest in the role of vitamin K nutritive status in childhood
bone health has heightened in recent times with the findings
that better vitamin K status was associated with decreased
bone turnover(10) and greater bone mineral content of total
body and lumbar spine(19) in healthy young girls. Of
concern, there is evidence that a high proportion of girls
have suboptimal dietary vitamin K intake and/or vitamin K
status(18,19,28,29). Thus, with this in mind, strategies for
improving vitamin K status during childhood and adolescence
need to be developed. Various lines of epidemiological evi-
dence point towards a nutritional interaction between markers
of vitamin D and vitamin K status(10,19,20 – 22). A causal
relationship between vitamin D and vitamin K, should it exist,
would offer a possible indirect benefit of increasing vitamin D
intake to bone health. The findings of the present study,
however, which had the possibility that improving vitamin D
status of young adolescent girls would decrease serum %ucOC
as its central hypothesis, do not support this notion.
While vitamin D status, as reflected by serum 25(OH)D
concentration, was significantly increased by vitamin D3
supplementation in the girls, serum %ucOC was not reduced.
The lack of effect of vitamin D supplementation on serum
%ucOC in adolescent girls in the present study, which to
our knowledge is the first to investigate this directly, is in
line with recently reported lack of effect of vitamin D3
supplementation (plus Ca) on serum ucOC in postmenopausal
women(24). In contrast, Szulc et al.(10) showed that vitamin D3
plus Ca supplementation significantly reduced the %ucOC
in elderly women. There is no other report of vitamin D
supplementation alone on serum %ucOC. Takahashi et al.(30)
reported no effect of 1mg of 1a-hydroxyvitamin D3 (a syn-
thetic pro-drug of the active form of vitamin D) on ucOC in
elderly osteoporotic patients with vertebral fractures. Further-
more, Bolton-Smith et al.(24) and Takahashi et al.(30) failed to
find any evidence of an additive effect of supplementation
with vitamin K and vitamin D (alone or plus Ca) on
%ucOC. It is possible that the inverse associations observed
between serum 25(OH)D and %ucOC in our young girls at
baseline(19), as well as in older women(10), may simply reflect
the fact that the two biochemical measures track healthy diet
and/or lifestyles. However, given that the dietary and other
sources of vitamin D and vitamin K are so different, this
area requires more investigation.
The mean increment in serum 25(OH)D concentration
(10·3 nmol/l) over 12 months following daily supplementation
with 10mg vitamin D3 was similar to that reported recently in
similarly-aged Finnish girls supplemented for 12 months with
an equivalent dose of vitamin D3
( 31). There was a significant
decrease in mean serum 25(OH)D (28·1 nmol/l) in the pla-
cebo group over the 12-month intervention period. Viljakainen
et al.(31) also showed a decline in serum 25(OH)D concen-
tration over 12 months in a group of 11-year-old Finnish
girls randomised to a placebo treatment and sampled during
wintertime. The reasons for this decrease in serum 25(OH)D
over time are not clear, but may relate to the advancing
sexual maturity of the girls over the 12 months. For example,
Tanner stage has been shown to negatively relate to serum
25(OH)D in children, aged 10–16 years(32), although Ginty
et al.(33), while reporting a decrease in serum 25(OH)D with
advancing Tanner stage in boys (aged 11–16 years), did not
see this relationship in girls. The increased rate of bone accre-
tion during the pubertal spurt requires adequate serum Ca
levels, and 25(OH)D may be more rapidly converted to
1,25-dihydroxyvitamin D3 to support the bone metabolic
activity at this life-stage. Alternatively, the decrease in
serum 25(OH)D may reflect differences in vitamin D stores
achieved in these girls during the two preceding summers aris-
ing from differences in sun exposure and/or vitamin D intake
during these times. Serum %ucOC increased in both groups
over time. This, again, may have been related to the advancing
sexual maturity of the girls over the 12-month intervention
period. For example, Van Summeren et al.(29) recently
reported that the ratio between ucOC and carboxylated osteo-
calcin (i.e. %ucOC) was highest at the end of puberty (Tanner
stage V; 2·7) and during puberty (Tanner stages II–IV; 2·6)
compared with pre-puberty (Tanner stage I; 2·0), although
Table 1. Serum 25-hydroxyvitamin D (25(OH)D) (nmol/l) and serum percentage undercarboxylated osteocalcin
(%ucOC) pre- and post-vitamin D (10mg/d) intervention
(Mean values and standard deviations)
Pre-intervention Post-intervention
Placebo (n 34) Vitamin D3 (n 33) Placebo (n 34) Vitamin D3 (n 33)
Mean SD Mean SD Mean SD Mean SD
Serum 25(OH)D 47·8 18·4 47·6 15·8 39·7† 17·7 57·9* 14·3
Serum %ucOC 24·0 5·2 22·5 3·4 27·8* 5·7 26·7* 7·0
* Mean value was significantly increased relative to pre-intervention concentration within a group (P,0·05).
† Mean value was significantly decreased relative to pre-intervention concentration within placebo group (P,0·003).
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these were not statistically compared. The authors suggest that
the high %ucOC in children compared with that seen in adults
in their study may be suggestive of subclinical vitamin K
deficiency during high bone turnover in children(29). Whether
a high %ucOC has a detrimental effect on bone health out-
comes in children requires further investigation. Data from
available randomised controlled trials with vitamin K (alone
or in combination with other micronutrients) in older adults
have produced mixed findings in relation to its effect on
bone mineral density even though it significantly reduced
%ucOC (or ucOC where %ucOC was not reported) in all
studies(24,34 – 37). However, vitamin K may lower the risk of
osteoporotic fractures by other mechanisms, such as through
effects on bone quality parameters, an area which would
also require more research(29,38).
In conclusion, improving vitamin D status did not reduce
serum %ucOC in adolescent girls. Other strategies for improv-
ing vitamin K status need to be explored, especially as a high
percentage of adolescent girls appear to have low vitamin K
status(18,19,28,29). While achieving dietary recommendations
for vitamin K would seem the best way forward in terms of
improving status, there is evidence that phylloquinone intakes
in many children and adolescents are below the recommended
level(18,27,39 – 42). For example, in a representative sample of
Irish children aged 5–12 years about half of all boys and
girls had suboptimal phylloquinone intakes(42). Further
research is needed to explore strategies of promoting vitamin
K intake during childhood.
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